Vietnam Investment Review on MSN10h
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
Telix Pharmaceuticals Limited today announces that the United States Food and Drug Administration has approved its New Drug ...
Up 113% in a year, guess which ASX 200 healthcare stock just scored another FDA win
The ASX 200 healthcare stock received another FDA approval for its cancer detection product. The post Up 113% in a year, ...
Targeted Oncology14h
FDA OKs TLX007-CDx in Prostate Cancer Treatment
TLX007-CDx is a cold kit designed for the preparation of PSMA-targeted PET imaging for prostate cancer. It leverages ...
UroToday13h
Prostate Cancer
Association of marginalization and PSMA-PET in prostate cancer: An analysis of the Ontario PSMA-PET Registry for Recurrent Prostate Cancer. March 7, 2025 Quality of Life Two Years After Diagnosis of ...